The board of directors at TriSalus Life Sciences comprises experienced healthcare executives, investors, and medical experts who provide governance and strategic oversight. Key members include Mats L. Wahlström (Chairman), Mary Szela (Chief Executive Officer and Director), alongside experienced directors such as Kelly Martin, David J. Matlin, Andrew C. von Eschenbach, Arjun Desai, Kerry Hicks, and Anil Singhal, who collectively guide the enterprise's long-term clinical and financial goals.